Login

Biotec Pharmacon presentation - Christian Jorgensen, CEO, Biotec Pharmacon A 00:00:00

Share On Facebook Share On Twitter

Biotec Pharmacon presentation

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Understanding Asset Allocation: Key Considerations | Steve Cruice - Founder and Lead Advisor of Simply Steward
00:10:00
Exciting Developments and Strategic Partnerships in Azumah Resources' Ghanaian Gold Project
00:10:00
Recover Funds from Coin Aate Scams with MFG Inc
00:10:00
Glenn August on Credit Markets: Navigating Pandemic Recovery and Finding Value |Glenn August , CEO, Oak Hill Advisors.
00:10:00
A natural evolution of the firm’s activity as a principal investor in corporate equity and debt|Rich Friedman,Chairman,Goldman Sachs Asset Management
00:10:00
Mastering Arbitrage Funds: Insights and Strategies for Smarter Investing | Bhavesh Jain - Co-Head, Factor Investing, Edelweiss Mutual Fund
00:10:00
2025 Final Rule & AEP Updates Explained | Bob Bryszki, VP of Marketing, and Rob Valincius, Director of Agent Training at Pinnacle Financial Services
00:10:00
Introduction to Trek Metals Limited
00:10:00
BBVA's Strong Performance in First 9 Months of 2023 | Onur Genç , CEO , BBVA .
00:10:00
Misbehaving: The Evolution of Behavioral Economics – A Conversation with Richard Thaler and Google's Chief Economist Hal Varian at Talks at Google
00:10:00
SRG Mining: Pioneering Graphite Supply Diversification for EV Batteries
00:10:00
Instem PLC's CEO Phil Reason discusses the company's robust 2022 financial performance, marked by a 28% revenue growth, 32% increase in underlying earnings, and anticipated benefits from industry consolidation in 2023, alongside recent successes such as h

© 2026 Nehu